A daily preventive pill can be invaluable for people at risk for HIV. But some doctors don't know much about prescribing them. And billing headaches are common. Here's how to overcome those hurdles.

There's no vaccine for HIV, the virus that can lead to AIDS. And stories about people being cured of HIV are still read as miracles. HIV can, however, be prevented, controlled and treated with tablets ...

Despite highly effective HIV prevention drugs on the market, only a fraction of those at risk in the U.S. are taking them — or even know they're an option. It's called pre-exposure prophylaxis, or ...

The GU Clinic issued prescriptions for medication that helps prevent HIV infection to 457 patients in 2025, Health Minister ...

It’s been over a decade since the Food and Drug Administration first approved a medication to prevent HIV. But the Centers for Disease Control and Prevention estimates just 30% of the 1.2 million ...

Nationwide, an estimated 1.2 million people are eligible to receive medication that can prevent the spread of life-threatening HIV infection. But only roughly a third of those eligible are currently ...

This is a KFF Health News story. A proposed federal policy aims to protect older Americans from contracting HIV by offering free preventive medication, the latest effort to catch up to much of Europe ...

Eight times more American young adults now take medication to protect them from HIV than a decade ago, a new study finds. But even with this positive news about increasing use of pre-exposure ...

In a recent study published in JAMA Network Open, a group of researchers assessed the risk of hypertension and statin initiation in adults starting Human Immunodeficiency Virus (HIV) Pre-exposure ...

In 2023, the World Health Organization (WHO) hailed Vietnam as a leading country in the Asia-Pacific region in HIV pre-exposure prophylaxis (PrEP) treatment.

Novel findings attend to attitudes of the stigmatized, rather than stigmatizers Past research identified perception of promiscuity and assumptions that PrEP users are HIV-positive as key drivers of ...